Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:8472312.
doi: 10.1155/2017/8472312. Epub 2017 May 8.

Effect of Naringenin, Quercetin, and Sesamin on Xenobiotica-Metabolizing CYP1A and CYP3A in Mice Offspring after Maternal Exposure to Persistent Organic Pollutants

Affiliations

Effect of Naringenin, Quercetin, and Sesamin on Xenobiotica-Metabolizing CYP1A and CYP3A in Mice Offspring after Maternal Exposure to Persistent Organic Pollutants

Nadezhda Pilipenko et al. Biomed Res Int. 2017.

Abstract

The aim of the present study was to evaluate in vitro effects of dietary phytochemicals naringenin, quercetin, and sesamin on the activities of ethoxy- (EROD; CYP1A) and benzyloxy- (BROD; CYP3A) resorufin O-dealkylases after the exposure to the cocktail of persistent organic pollutants (POPs). CD-1 mice were exposed from weaning, through gestation and lactation to a defined mixture of POPs. Hepatic microsomes were prepared from their female offspring at postnatal day 42. Hepatic EROD and BROD activity were evaluated in the presence of quercetin, naringenin, and sesamin at nine concentrations from 5 to 100000 nM. EROD activity was strongly inhibited by quercetin with Ki values from 1.7 to 2.6 μM. BROD activity was inhibited by quercetin with Ki values from 64.9 to 75.3 μM and naringenin with Ki values from 39.3 to 45.8 μM. The IC50 and Ki values did not differ between the groups of mice with different levels of POPs exposure in any of the experimental sets. Sesamin did not inhibit either EROD or BROD. We concluded that the interactions of quercetin and naringenin with CYP1A and CYP3A in mice liver were not affected by the levels of POPs exposure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
In vitro inhibition of CYP1A by quercetin, naringenin, and sesamin in the microsomes from mice exposed to different levels of POPs (n = 6 mice per group). CYP1A activity was measured by the rate of 7-ethoxyresorufin O-deethylation. Data are presented as the mean percentage of remaining activity and standard error of the enzyme activity in 6 mice.
Figure 2
Figure 2
Michaels-Menten kinetics of 7-ethoxyresorufin O-dealkylation with or without quercetin in the microsomes from mice exposed to different levels of POPs.
Figure 3
Figure 3
In vitro inhibition of CYP3A by quercetin, naringenin, and sesamin in hepatic microsomes from mice exposed to different levels of POPs (n = 6 mice per group). CYP3A activity was measured by the rate of 7-benzyloxyresorufin O-debenzylation. Data are presented as the mean percentage of remaining activity and standard error of the enzyme activity in 6 mice.
Figure 4
Figure 4
Michaels-Menten kinetics of 7-benzoxyresorufin O-dealkylation with or without quercetin in the microsomes from mice exposed to different levels of POPs.
Figure 5
Figure 5
Michaels-Menten kinetics of 7-benzoxyresorufin O-dealkylation with or without naringenin in the microsomes from mice exposed to different levels of POPs.

Similar articles

Cited by

References

    1. Bandiera S. M. Cytochrome P450 enzymes as biomarkers of PCB exposure and modulation of toxicity. In: Robertson P. L. W., Hansen L. G., editors. Recent Advances in the Environmental Toxicology and Health Effects. Lexington, Ky, Kentucky: University Press of Kentucky; 2001. pp. 185–192.
    1. Tabrez S., Ahmad M. Cytochrome P450 system as a toxicity biomarker of industrial wastewater in rat tissues. Food and Chemical Toxicology. 2010;48(3):998–1001. doi: 10.1016/j.fct.2009.12.024. - DOI - PubMed
    1. Nebert D. W., Dalton T. P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nature Reviews Cancer. 2006;6(12):947–960. doi: 10.1038/nrc2015. - DOI - PubMed
    1. Rodriguez-Antona C., Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006;25(11):1679–1691. doi: 10.1038/sj.onc.1209377. - DOI - PubMed
    1. Zanger U. M., Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics. 2013;138(1):103–141. doi: 10.1016/j.pharmthera.2012.12.007. - DOI - PubMed

MeSH terms

LinkOut - more resources